Big Pharma wages stealth war on drug price watchdog - Reuters

4:07am PDT - September 11th, 2020    first day of fall 2020 usa - Reuters

As evidence grew this spring that the drug remdesivir was helping COVID-19 patients, some Wall Street investors bet on analysts’ estimates that its maker, Gilead Sciences Inc, could charge up to $10,000 for the treatment.